BACKGROUND:Human papillomavirus (HPV) testing has relied to date on samples collected by experienced health professionals. Self-administered testing devices could allow HPV testing to occur in large-scale epidemiologic studies of primary care screening populations. The purpose of this study is to determine whether a self-collection device for cervicovaginal HPV infection could be developed. METHODS: A prospective randomized trial of a consecutive sampling of 93 women, 18 years or older, receiving routine cervical cancer screening and colposcopy in the urban gynecologic clinics in Philadelphia, Pennsylvania, were randomized into 2 arms. Women in arm 1 used a self-administered tampon before the physician-directed swabs of the cervix; in arm 2, women underwent the physician-directed swab testing before using the self-administered tampon. The concordance of HPV DNA positivity between sampling methods detected by a Hybrid Capture HPV tube test for both low- and high-risk types of HPV was the main outcome measure. RESULTS: The concordance rate (ie, women whose cultures were classified as negative on both tests or positive on both tests) for arms 1 and 2 were similar: 78.3% and 80.9%, respectively. CONCLUSIONS: The tampon was equivalent to the physician-directed swab in HPV detection and suggests its feasibility in long-term primary care studies of screening populations.
RCT Entities:
BACKGROUND:Human papillomavirus (HPV) testing has relied to date on samples collected by experienced health professionals. Self-administered testing devices could allow HPV testing to occur in large-scale epidemiologic studies of primary care screening populations. The purpose of this study is to determine whether a self-collection device for cervicovaginal HPV infection could be developed. METHODS: A prospective randomized trial of a consecutive sampling of 93 women, 18 years or older, receiving routine cervical cancer screening and colposcopy in the urban gynecologic clinics in Philadelphia, Pennsylvania, were randomized into 2 arms. Women in arm 1 used a self-administered tampon before the physician-directed swabs of the cervix; in arm 2, women underwent the physician-directed swab testing before using the self-administered tampon. The concordance of HPV DNA positivity between sampling methods detected by a Hybrid Capture HPV tube test for both low- and high-risk types of HPV was the main outcome measure. RESULTS: The concordance rate (ie, women whose cultures were classified as negative on both tests or positive on both tests) for arms 1 and 2 were similar: 78.3% and 80.9%, respectively. CONCLUSIONS: The tampon was equivalent to the physician-directed swab in HPV detection and suggests its feasibility in long-term primary care studies of screening populations.
Authors: G S Ogilvie; D M Patrick; M Schulzer; J W Sellors; M Petric; K Chambers; R White; J M FitzGerald Journal: Sex Transm Infect Date: 2005-06 Impact factor: 3.519
Authors: Isabel C Scarinci; Allison G Litton; Isabel C Garcés-Palacio; Edward E Partridge; Philip E Castle Journal: Womens Health Issues Date: 2013-02-12
Authors: Romy van Baars; Remko P Bosgraaf; Bram W A ter Harmsel; Willem J G Melchers; Wim G V Quint; Ruud L M Bekkers Journal: J Clin Microbiol Date: 2012-09-26 Impact factor: 5.948
Authors: Diane M Harper; Meghan R Longacre; Walter W Noll; Dorothy R Belloni; Bernard F Cole Journal: Ann Fam Med Date: 2003 Nov-Dec Impact factor: 5.166
Authors: Philip E Castle; Julia C Gage; Edward E Partridge; Alfio Rausa; Patti E Gravitt; Isabel C Scarinci Journal: BMC Infect Dis Date: 2013-01-07 Impact factor: 3.090
Authors: Natalie Marya Alexander; Diane Medved Harper; Johanna Claire Comes; Melissa Smith Smith; Melinda Ann Heutinck; Sandra Martin Handley; Debra Ann Ahern Journal: PLoS One Date: 2014-06-10 Impact factor: 3.240